Last updated 6 days ago

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

1104 patients around the world
Available in Argentina, Puerto Rico, United States
Merck Sharp & Dohme LLC
3Research sites
1104Patients around the world

This study is for people with

Diabetic retinopathy
Diabetic macular edema

Requirements for the patient

From 18 Years
All Gender

Medical requirements

The main inclusion criteria include but are not limited to the following.
Has Type 1 or Type 2 diabetes mellitus and a hemoglobin A1c (HbA1c) of ≤12%.
Has a decrease in vision in the study eye determined by the Investigator to be primarily the result of diabetic macular edema (DME).
For participants who are treatment-naïve for DME, the diagnosis must have been made within 9 months of screening. For all treatment-experienced participants, the first treatment should have been no longer than 3 years prior to the Screening visit.
The main exclusion criteria include but are not limited to the following.
Has had renal failure requiring renal transplant, hemodialysis, or peritoneal dialysis or has renal failure anticipated to require hemodialysis or peritoneal dialysis at any time during the study.
Has history of stroke (cerebral vascular accident) or myocardial infarction within 180 days to first dose of study intervention.
Has newly diagnosed or previously untreated diabetes mellitus and initiated oral or injectable anti-diabetic medication within 3 months to first dose of study intervention.
Has history of cataract surgery and/or minimally invasive glaucoma surgery in the study eye within 90 days of screening.
Has any treatment for complications of cataract surgery with steroids or yttrium aluminum garnet (YAG) laser capsulotomy in the study eye within 90 days of screening.
Has advanced or uncontrolled glaucoma in the study eye.
Has any history of retinal detachment or treatment or surgery for retinal detachment in the study eye.
Has active retinal disease other than the condition under investigation in the study eye.
Has uncontrolled blood pressure at screening.

Sites

Clínica Privada Ojos Romagosa
Recruiting
Dean Funes 432, Córdoba
IMOC - Instituto de Microcirugía Ocular Córdoba
Recruiting
Wenceslao Paunero 2193, X5000 Córdoba, Argentina
Emanuelli Research and Development Center LLC
Recruiting
16 Calle Garcia, Arecibo, 00612, Puerto Rico
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy